" /> Sorafenib - CISMeF





Preferred Label : Sorafenib;

NCIt related terms : BAY 43-9006;

NCIt definition : A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.;

Alternative definition : NCI-GLOSS: A drug used to treat advanced kidney cancer and a type of liver cancer that cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. Sorafenib stops cells from dividing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of kinase inhibitor and a type of antiangiogenesis agent.;

UNII : 9ZOQ3TZI87;

InChIKey : MLDQJTXFUGDVEO-UHFFFAOYSA-N;

CAS number : 284461-73-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 284461-73-0 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : BAY 43-9006; Bay-439006; BA4 43 9006;

Chemical formula : C21H16ClF3N4O3;

ChEBI ID : CHEBI:50924;

Codes from synonyms : CDR0000306493; 50517; CDR0000390251; 470;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.